Skip to main content
. 2020 Oct 2;11:4966. doi: 10.1038/s41467-020-18757-2

Fig. 6. Assessment of D-serine levels in MEA and summary of neuroglia changes in TLE.

Fig. 6

a Representative electropherograms of the secreted fractions from MEA (top row), LEA (middle row), and the cerebellum (bottom row) of non-status control and epileptic rats. Peak identification: (1) L-Ser; (2) D-Ser; (3) L-Asn; (4) L-Thr; (5) L-Gln; (6) L/D-Glu + D-Gln + D-Thr; (7) β-HSer (internal standard); (8) L/D-Asp; (9) L-His; (10) Gly; (11) L/D-Ala; (12) α-ABA (IS); (13) L-Tyr; (14) D-Tyr; (15) L-Met; (16) D-Met; (17) β-Ala; (18) L-Val; (19) D-Val; (20) Tau; (21) GABA; (22) L-Ile + L/D-Leu; (23) L/D-Phe; (24) L-Trp; (25) D-Trp; (26) β-Phe (IS); and (27) L/D-Arg. Insets (rightmost panel) are overlays of zoomed-in images of electropherograms from control (black) and epileptic (red) animals highlighting differences in the normalized fluorescence intensities of the L- and D-serine peaks (time-shifted to facilitate viewing). The bars atop peaks facilitate viewing of the amplitude differences. b Raw data and histograms of average D-serine levels in brain tissue (supernatant or secreted fraction, left panel; cell homogenate fraction, right panel) from the indicated regions of non-status control and epileptic rats expressed in μg/g of brain tissue (top panels) and as a percentage of total serine (D + L, bottom panels) within the samples. Numbers within bar plots indicate animals used (n) and the inset identifies location of LEA, presubiculum (PrS), and parasubiculum (Par) relative to the MEA. *p < 0.05, ***p < 0.001, Student’s t test. Error bars represent SEM. c Summary of neuroglia changes characterizing TLE pathology and two possible avenues through which D-serine might mitigate cell loss within the MEA.